Earlier this year the drug developer Geron Corp. announced that it was given FDA approval to begin the first trial of an embryonic stem cell treatment in humans. But alas, the FDA reversed its decision this week:
Geron said the Food and Drug Administration is reviewing new data from studies of the therapy, called GRNOPC1, on animals. The company plans to start testing its product on humans this summer, but that testing will be delayed during the FDA’s review. Geron said it will work with the FDA, and did not estimate how long the review will take.
This is good news! The more we can delay the progression of this unethical and immoral science the better. Meanwhile, ethical stem cells continue to kick butt and outperform – in animals as well as many humans. Full speed ahead!